 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

Watchers	163
52-Wk Low	$0.00
52-Wk High	$0.00

Market Cap	$0.00
Volume (M)	14,581.00
52-Wk High	$0.00
52-Wk Low	$0.00

ABLX Ablynx NV

About

Feed

News

Fundamentals